ALDURAZYME
Live / Registered — Registered and renewed (as of 07 May 2018)
What this means for you
Registered since 12 Feb 2008. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 12 Feb 2018).
Record
- Serial number
- 77118358
- Registration number
- 3380455
- Mark type
- Design + words
- Filed
- 28 Feb 2007
- Published for opposition
- 27 Nov 2007
- Registered
- 12 Feb 2008
- Next maintenance due
- 12 Feb 2018
- Attorney of record
- Karen Lim
Goods and services
- Class 005 — Pharmaceuticals: Drug for treating lysosomal storage diseases
Owner
- BIOMARIN/GENZYME LLC, Cambridge, MA, US
- BIOMARIN/GENZYME LLC, CAMBRIDGE, MA, US
- BIOMARIN/GENZYME LLC, CAMBRIDGE, MA, US
- Genzyme Corporation, Cambridge, MA, US
Prior registrations
Prosecution history
- 08 Jan 2020 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
- 10 Dec 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 20 Jun 2018 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 20 Jun 2018 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 07 May 2018 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 07 May 2018 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 07 May 2018 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 07 May 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 25 Apr 2018 — TEAS SECTION 8 & 9 RECEIVED
- 05 Apr 2017 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
- 31 Jan 2017 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 12 Feb 2017 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 10 Feb 2014 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 10 Feb 2014 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 29 Jan 2014 — REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED